Commodore Capital’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.1M | Sell |
610,000
-540,000
| -47% | -$45.2M | 3.61% | 12 |
|
|
2025
Q1 | $82.2M | Sell |
1,150,000
-375,000
| -25% | -$26.8M | 6.05% | 4 |
|
|
2024
Q4 | $68.5M | Buy |
1,525,000
+265,000
| +21% | +$11.9M | 5.02% | 7 |
|
|
2024
Q3 | $63.6M | Sell |
1,260,000
-165,000
| -12% | -$8.33M | 3.98% | 9 |
|
|
2024
Q2 | $58.1M | Buy |
1,425,000
+1,255,467
| +741% | +$51.2M | 3.97% | 8 |
|
|
2024
Q1 | $7.26M | Sell |
169,533
-530,467
| -76% | -$22.7M | 0.49% | 34 |
|
|
2023
Q4 | $28.2M | Sell |
700,000
-187,500
| -21% | -$7.55M | 2.46% | 15 |
|
|
2023
Q3 | $26.2M | Buy |
+887,500
| New | +$26.2M | 3.06% | 14 |
|